In a trial to attenuate the proinflammatory reaction of astroglia mediated by NF-κB expression, transgenic models with relatively inhibited NF-κB expression were used and showed a significant reduction in white matter injury in disease models of autoimmune encephalomyelitis and ischemic stroke [8]. Here, NFKB1 is linked to ischemic stroke.